Delivery Order SPE2DB20D1100-SPE2DB25FC0K5
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$69K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,060.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,022.25 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, with a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,922.18 firm fixed-price delivery order is for the medication Biktarvy, a treatment for HIV. The contract has a completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor. The $30,867.75 delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, to support military treatment programs and facilities. The contract has an ultimate completion date of October 11, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $78,159.94, is a delivery order for Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of December 5, 2024 and is a firm fixed price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $19,773.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the prescription medication Biktarvy, a treatment for human immunodeficiency virus (HIV). The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Additionally, AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,515.71, is a Delivery Order for the supply of Biktarvy 50-200-25 mg tablets. It is a Firm Fixed Price contract with a period of performance through May 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,625.39, is a Firm Fixed Price Delivery Order for the provision of the drug Biktarvy, a medication used to treat HIV. The contract has an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $18,961.41 firm fixed-price delivery order is for the supply of Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of October 8, 2024 and does not utilize a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,735.24, is a delivery order for Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price type. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...